TR199903192T2 - Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar. - Google Patents

Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.

Info

Publication number
TR199903192T2
TR199903192T2 TR1999/03192T TR9903192T TR199903192T2 TR 199903192 T2 TR199903192 T2 TR 199903192T2 TR 1999/03192 T TR1999/03192 T TR 1999/03192T TR 9903192 T TR9903192 T TR 9903192T TR 199903192 T2 TR199903192 T2 TR 199903192T2
Authority
TR
Turkey
Prior art keywords
preparations containing
erythropoietin
modified hemoglobin
combined preparations
containing erythropoietin
Prior art date
Application number
TR1999/03192T
Other languages
English (en)
Turkish (tr)
Inventor
Lehmann Paul
Town Michael-Harold
Feurstein Jurgen
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR199903192T2 publication Critical patent/TR199903192T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1999/03192T 1997-06-21 1998-06-03 Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar. TR199903192T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97110168A EP0885613A1 (de) 1997-06-21 1997-06-21 Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin

Publications (1)

Publication Number Publication Date
TR199903192T2 true TR199903192T2 (xx) 2000-05-22

Family

ID=8226937

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03192T TR199903192T2 (xx) 1997-06-21 1998-06-03 Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.

Country Status (15)

Country Link
US (3) US6440932B1 (enExample)
EP (2) EP0885613A1 (enExample)
JP (3) JP2002504913A (enExample)
KR (1) KR100519904B1 (enExample)
CN (1) CN1185010C (enExample)
AT (1) ATE272405T1 (enExample)
AU (1) AU743475B2 (enExample)
BR (1) BR9810267A (enExample)
CA (1) CA2294448C (enExample)
DE (1) DE59811768D1 (enExample)
DK (1) DK0996462T3 (enExample)
ES (1) ES2226151T3 (enExample)
PT (1) PT996462E (enExample)
TR (1) TR199903192T2 (enExample)
WO (1) WO1998058660A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0977582B1 (de) * 1997-03-18 2002-08-14 Roche Diagnostics GmbH Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
ATE291436T2 (de) * 2000-05-15 2005-04-15 Hoffmann La Roche Flüssige arzneizubereitung enthaltend ein erythropoietin derivat
AU3323002A (en) 2000-12-20 2002-07-01 Hoffmann La Roche Erythropoietin conjugates
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
WO2005032467A2 (en) 2003-09-29 2005-04-14 Warren Pharmaceuticals, Inc. Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
RU2273485C2 (ru) * 2004-05-19 2006-04-10 Виктор Николаевич Алейников Железосодержащий препарат "феррал"
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
EP2054074B8 (en) 2006-08-04 2014-11-12 Prolong Pharmaceuticals, LLC Modified erythropoietin
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
WO2017091568A1 (en) 2015-11-23 2017-06-01 Bristol-Myers Squibb Company Additive systems for use in protein pegylation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
KR880012235A (ko) * 1987-04-10 1988-11-26 벤자민 에프.람버트 정상 포유동물의 헤마토크릿을 증가시키는 방법
JPH03112934A (ja) * 1989-09-27 1991-05-14 Mitsubishi Kasei Corp 圧縮成型可能な粉体組成物
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
JPH09507867A (ja) * 1994-11-17 1997-08-12 バクスター、インターナショナル、インコーポレイテッド 血液透析におけるヘモグロビン療法
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
WO1998008537A1 (en) 1996-08-27 1998-03-05 Hemosol Inc. Enhanced stimulation of erythropoiesis

Also Published As

Publication number Publication date
WO1998058660A1 (de) 1998-12-30
JP5785008B2 (ja) 2015-09-24
CN1261282A (zh) 2000-07-26
EP0996462B1 (de) 2004-08-04
JP2007246530A (ja) 2007-09-27
JP2011246474A (ja) 2011-12-08
EP0885613A1 (de) 1998-12-23
US20020160956A1 (en) 2002-10-31
US6440932B1 (en) 2002-08-27
KR100519904B1 (ko) 2005-10-10
DK0996462T3 (da) 2004-11-29
CA2294448C (en) 2007-12-11
DE59811768D1 (de) 2004-09-09
ATE272405T1 (de) 2004-08-15
ES2226151T3 (es) 2005-03-16
JP2002504913A (ja) 2002-02-12
US20050197281A1 (en) 2005-09-08
EP0996462A1 (de) 2000-05-03
BR9810267A (pt) 2000-09-12
CN1185010C (zh) 2005-01-19
AU8109898A (en) 1999-01-04
PT996462E (pt) 2004-12-31
KR20010014075A (ko) 2001-02-26
AU743475B2 (en) 2002-01-24
CA2294448A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
AU610636B2 (en) Stabilised human protein preparations
ES2139678T3 (es) Uso de eritropoyetina para la preparacion de una composicion farmaceutica para administracion pulmonar o inhalacion.
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
ES2130428T3 (es) Cristales de insulina asp-b28.
ATE223204T1 (de) Liposomenzusammensetzung
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
IL85651A0 (en) Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
ATE45956T1 (de) 11 beta-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.